Suppr超能文献

从亲本和长春新碱耐药的HOB1淋巴瘤细胞中纯化和鉴定微管蛋白。

Purification and characterization of tubulin from parental and vincristine-resistant HOB1 lymphoma cells.

作者信息

Lee W P

机构信息

Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China.

出版信息

Arch Biochem Biophys. 1995 Jun 1;319(2):498-503. doi: 10.1006/abbi.1995.1322.

Abstract

A multidrug-resistant lymphoma cell line resistant to 1.0 microM vincristine (designated HOB1/VCR1.0) was established. The tubulins of parental and resistant cell lines were purified by ion-exchange chromatography. Two-dimensional polyacrylamide gel electrophoresis of tubulins showed a decrease in the basic component of beta-tubulin in the HOB1/VCR1.0 cell line; native isoelectric focusing of tubulins showed decreased expression of two more basic tubulin dimers in the same cell line. The [3H]vincristine-tubulin binding studies were performed by filtration and HPLC and displayed the tubulin of HOB1/VCR1.0 cells having a weaker binding affinity to vincristine than those of parental HOB1 and HOB1/VCR0.5 cells. The binding constant Ka of purified tubulin to vincristine, calculated from the slope of the Scatchard curve, for parental HOB1 cells was 5.6 x 10(6), and that for HOB1/VCR1.0 cells was 3.1 x 10(6). The Scatchard kinetics was also used to determine the binding ability of the purified tubulins to [3H]colcemid: the Kas for parental and HOB1/VCR1.0 cells were 3.9 x 10(5) and 2.0 x 10(5), respectively. The current study suggests that high-level resistant cells, HOB1/VCR1.0, tend to express fewer tubulin isoforms of stronger binding affinities to antimitotic agents; that is, they preserve weak drug-binding forms rather than produce additional species. This may be a mechanism for the cells to protect themselves from drug injury when the P-glycoprotein cannot efficiently pump out the agent of high concentration within the cells.

摘要

建立了对1.0微摩尔长春新碱耐药的多药耐药淋巴瘤细胞系(命名为HOB1/VCR1.0)。通过离子交换色谱法纯化亲本细胞系和耐药细胞系的微管蛋白。微管蛋白的二维聚丙烯酰胺凝胶电泳显示,HOB1/VCR1.0细胞系中β-微管蛋白的碱性成分减少;微管蛋白的天然等电聚焦显示,同一细胞系中另外两种碱性更强的微管蛋白二聚体表达减少。通过过滤和高效液相色谱法进行[3H]长春新碱-微管蛋白结合研究,结果显示HOB1/VCR1.0细胞的微管蛋白与长春新碱的结合亲和力比亲本HOB1细胞和HOB1/VCR0.5细胞的微管蛋白弱。根据Scatchard曲线的斜率计算,纯化的微管蛋白与长春新碱的结合常数Ka,亲本HOB1细胞为5.6×10(6),HOB1/VCR1.0细胞为3.1×10(6)。Scatchard动力学也用于确定纯化的微管蛋白与[3H]秋水仙酰胺的结合能力:亲本细胞和HOB1/VCR1.0细胞的Ka分别为3.9×10(5)和2.0×10(5)。当前研究表明,高水平耐药细胞HOB1/VCR1.0倾向于表达与抗有丝分裂剂结合亲和力更强的微管蛋白异构体较少;也就是说,它们保留弱药物结合形式而非产生额外的种类。当P-糖蛋白不能有效地将高浓度药物泵出细胞时,这可能是细胞保护自身免受药物损伤的一种机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验